AI English summary of an SEC filing — figures as filed
Quest Diagnostics DGXQuest Diagnostics announced on October 6, 2026 that Catherine T. Doherty will retire in July 2027.
Key points
AI summaryQuest Diagnostics announced on October 6, 2026 that Catherine T. Doherty will retire in July 2027.
The company said that until her retirement, Ms. Doherty will transition effective November 1, 2026 to a new role as Executive Vice President with responsibilities including health systems, the company's joint venture with Corewell Health, and Project Nova.
Quest Diagnostics said the Compensation and Leadership Development Committee approved no change to Ms. Doherty's annual base salary of $650,000 or annual incentive compensation under the Senior Management Incentive Plan with a target of 80% of base salary.
The company said the Committee approved an equity award under the Employee Long-Term Incentive Plan with a grant date of November 3, 2026 and a target value of $1,200,000, allocated 100% to restricted stock units.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Catherine T. Doherty to retire in July 2027
Quest Diagnostics announced on October 6, 2026 that Catherine T. Doherty will retire in July 2027.
Source · Based on the filing body and exhibits
Transition to Executive Vice President role effective November 1, 2026
The company said that until her retirement, Ms. Doherty will transition effective November 1, 2026 to a new role as Executive Vice President with responsibilities including health systems, the company's joint venture with Corewell Health, and Project Nova.
Source · Based on the filing body and exhibits
Annual base salary of $650,000 and target incentive of 80% maintained
Quest Diagnostics said the Compensation and Leadership Development Committee approved no change to Ms. Doherty's annual base salary of $650,000 or annual incentive compensation under the Senior Management Incentive Plan with a target of 80% of base salary.
Source · Based on the filing body and exhibits
Equity award with grant date November 3, 2026 and target value of $1,200,000
The company said the Committee approved an equity award under the Employee Long-Term Incentive Plan with a grant date of November 3, 2026 and a target value of $1,200,000, allocated 100% to restricted stock units.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…